Lewis Karen 4
4 · Apellis Pharmaceuticals, Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Lewis Karen
Chief People Officer
Transactions
- Sale
Common Stock
2023-02-23$68.76/sh−1,104$75,911→ 41,430 total
Footnotes (1)
- [F1]Sale originated from established 10b5-1 trading plan.